scholarly article | Q13442814 |
P50 | author | Raymond C Boston | Q122734096 |
P2093 | author name string | James C Coyne | |
John T Farrar | |||
Dorothy Cimino Brown | |||
P2860 | cites work | Development and validation of a questionnaire for measuring behavior and temperament traits in pet dogs | Q28184785 |
Pain assessment: global use of the Brief Pain Inventory | Q28247739 | ||
Health-Related Quality of Life and Depressive Symptoms in Adolescents With Extreme Obesity Presenting for Bariatric Surgery | Q29013034 | ||
Reliability of Katz's Activities of Daily Living Scale when used in telephone interviews | Q33551381 | ||
Outcome measures of antidepressive therapy. | Q33972272 | ||
Psychometric properties of the Stroke Impairment Assessment Set (SIAS). | Q34162312 | ||
Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis | Q34186962 | ||
Recognizing pain in the institutionalized elder with dementia | Q34234647 | ||
The RAND-36 measure of health-related quality of life | Q34329583 | ||
The PedsQL as a patient-reported outcome in children and adolescents with Attention-Deficit/Hyperactivity Disorder: a population-based study | Q34598924 | ||
Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale | Q35154789 | ||
Development of a questionnaire to measure the effects of chronic pain on health-related quality of life in dogs | Q80502987 | ||
Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia | Q80608981 | ||
Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting | Q80848280 | ||
The evaluation of extracorporeal shockwave therapy in naturally occurring osteoarthritis of the stifle joint in dogs | Q83084285 | ||
Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome | Q35675001 | ||
Dietary patterns and health outcomes. | Q35726241 | ||
Pain assessment and cognitive impairment: part 1. | Q35994020 | ||
Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma | Q35994441 | ||
The measurement of pain from metastatic bone disease: capturing the patient's experience | Q36633785 | ||
The SSA-profile, an instrument for assessment of subjective symptoms among hypertensives | Q37803884 | ||
Questionnaire for the Assessment of Symptoms and Psychological Effects in Cardiovascular Therapy (the ASPECT Scale). | Q37803886 | ||
The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia | Q39384216 | ||
Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. | Q39476553 | ||
Pain assessment and cognitive impairment: part 2. | Q39703970 | ||
Patient versus informant perspectives of Quality of Life in Mild Cognitive Impairment and Alzheimer's disease | Q40524296 | ||
A review of neuromotor tests and the construction of a scored neuromotor examination for four-year-olds | Q40654912 | ||
Clinical evaluation of a powder of quality elk velvet antler for the treatment of osteoarthrosis in dogs | Q41064206 | ||
Measurement issues in the comprehensive assessment of cancer pain | Q41361642 | ||
Validity of the Quality of Well-Being Scale for patients with Alzheimer's disease | Q41642088 | ||
Medical and behavioral surveillance of dogs deployed to the World Trade Center and the Pentagon from October 2001 to June 2002. | Q42028657 | ||
Validation of subjective measures of fatigue after elective operations | Q42601587 | ||
Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis | Q44034716 | ||
Hard Measures of Subjective Outcomes: Validating Symptom Indexes in Urology | Q44230460 | ||
Evaluation of a behavioral assessment questionnaire for use in the characterization of behavioral problems of dogs relinquished to animal shelters | Q46555446 | ||
Short-term outcome after total elbow arthroplasty in dogs with severe, naturally occurring osteoarthritis | Q47359077 | ||
The relationship between limb function and radiographic osteoarthrosis in dogs with stifle osteoarthrosis | Q47432483 | ||
Use of the Pediatric Quality of Life Inventory to assess the health-related quality of life in children with recurrent respiratory papillomatosis | Q47736379 | ||
Evaluation of health status and health-related quality of life in a cohort of Italian children following treatment for a primary brain tumor | Q48682341 | ||
Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. | Q50873892 | ||
Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC). | Q51007157 | ||
Quality of life in patients with Alzheimer's disease as reported by patient proxies. | Q51109852 | ||
Conceptualization and measurement of getting lost behavior in persons with early dementia. | Q51990247 | ||
Agreement between child self-report and parent proxy-report to evaluate quality of life in children with cancer. | Q52087345 | ||
A new readability yardstick. | Q52188030 | ||
Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. | Q52915655 | ||
Caregivers' judgments of the functional abilities of the Alzheimer's disease patient: a comparison of proxy reports and objective measures. | Q52929344 | ||
Assessment of discomfort in advanced Alzheimer patients. | Q53180272 | ||
Measuring functional competence in older persons with Alzheimer's disease. | Q53218092 | ||
Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire. | Q53265720 | ||
Pain and agitation in long-term care residents with dementia: use of the Pittsburgh Agitation Scale. | Q53268779 | ||
Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. | Q53672172 | ||
The Experience of Pain and Perceptions of Quality of Life: Validation of a Conceptual Model | Q67893713 | ||
A methodological framework for assessing health indices | Q70061009 | ||
The health impact of chronic recurrent rhinosinusitis in children | Q73180646 | ||
Randomised, double‐blind, placebocontrolled parallel group study of P54FP for the treatment of dogs with osteoarthritis | Q73336713 | ||
Pain Assessment for the Dementing Elderly (PADE): reliability and validity of a new measure | Q73528146 | ||
Validation of a pediatric voice quality-of-life instrument: the pediatric voice outcome survey | Q74576848 | ||
Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs | Q77928965 | ||
Measuring quality of life in children referred for psychiatric problems: psychometric properties of the PedsQL 4.0 generic core scales | Q79930619 | ||
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain | Q80476028 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteoarthritis | Q62736 |
chronic pain | Q1088113 | ||
P304 | page(s) | 631-637 | |
P577 | publication date | 2007-06-01 | |
P1433 | published in | American Journal of Veterinary Research | Q15754518 |
P1476 | title | Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis | |
P478 | volume | 68 |
Q37102307 | A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer |
Q33959287 | Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis |
Q92912538 | Adaptation of the Canine Orthopaedic Index to evaluate chronic elbow osteoarthritis in Swedish dogs |
Q38903010 | Anti-nerve growth factor therapy increases spontaneous day/night activity in mice with orthopedic surgery-induced pain |
Q91345502 | Assessment of quality of life and chronic pain in dogs |
Q40493723 | Client-assessed long-term outcome in dogs with surgical site infection following tibial plateau levelling osteotomy. |
Q34410470 | Clinical validity of outcome pain measures in naturally occurring canine osteoarthritis |
Q53191691 | Comparison of thermal and mechanical quantitative sensory testing in client-owned dogs with chronic naturally occurring pain and normal dogs. |
Q91962273 | Considerations for the Retirement of Therapy Animals |
Q92498187 | Contribution of Habitual Activity to Cruciate Ligament Rupture in Labrador Retrievers |
Q89963701 | Correlation of Artemin and GFRα3 With Osteoarthritis Pain: Early Evidence From Naturally Occurring Osteoarthritis-Associated Chronic Pain in Dogs |
Q37701031 | DJD-associated pain in cats: what can we do to promote patient comfort? |
Q47447810 | Development and preliminary psychometric evaluation of an owner-completed measure of feline quality of life |
Q48266533 | Development, validation and reliability of a web-based questionnaire to measure health-related quality of life in dogs |
Q38426135 | Dose reduction of meloxicam in dogs with osteoarthritis-associated pain and impaired mobility |
Q36475028 | Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis |
Q34433471 | Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis |
Q90542320 | Effectiveness of NEM® brand eggshell membrane in the treatment of suboptimal joint function in dogs: a multicenter, randomized, double-blind, placebo-controlled study |
Q89562315 | Electrophysiological characterisation of central sensitisation in canine spontaneous osteoarthritis |
Q37212008 | Evaluating oxidative stress, serological- and haematological status of dogs suffering from osteoarthritis, after supplementing their diet with fish or corn oil |
Q39924699 | Evaluation of Clinical Metrology Instrument in Dogs with Osteoarthritis |
Q39621080 | Evaluation of a Single Intra-Articular Injection of Autologous Protein Solution for Treatment of Osteoarthritis in a Canine Population. |
Q41208801 | Evaluation of a modified Karnofsky score to assess physical and psychological wellbeing of cats in a hospital setting |
Q34625608 | Evaluation of construct and criterion validity for the 'Liverpool Osteoarthritis in Dogs' (LOAD) clinical metrology instrument and comparison to two other instruments. |
Q34008711 | Evaluation of optimal sampling interval for activity monitoring in companion dogs |
Q35789388 | Evaluation of the effect of signalment and body conformation on activity monitoring in companion dogs |
Q88501997 | Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST) |
Q58694468 | Feasibility and reliability of electrical, mechanical and thermal nociceptive testing and assessment of diffuse noxious inhibitory control in dogs |
Q35785062 | Feasibility and repeatability of cold and mechanical quantitative sensory testing in normal dogs |
Q39229659 | Feline musculoskeletal pain index: responsiveness and testing of criterion validity |
Q37181731 | Functional outcome measures in a surgical model of hip osteoarthritis in dogs |
Q93005599 | Generation of Domains for the Equine Musculoskeletal Rehabilitation Outcome Score: Development by Expert Consensus |
Q57318961 | Guidelines for Recognition, Assessment and Treatment of Pain |
Q90838900 | Initial evaluation of PetPace activity monitor |
Q91851595 | Initial psychometric testing and validation of the French version of the Canine Brief Pain Inventory |
Q39185262 | Intra-Articular Hyaluronic Acid Compared to Traditional Conservative Treatment in Dogs with Osteoarthritis Associated with Hip Dysplasia |
Q27316416 | Intrathecal resiniferatoxin in a dog model: efficacy in bone cancer pain |
Q37404162 | Intrathecal substance P-saporin in the dog: efficacy in bone cancer pain |
Q44873882 | Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial. |
Q92428241 | Measurement of chronic pain in companion animals: Discussions from the Pain in Animals Workshop (PAW) 2017 |
Q88999533 | Measuring pain in dogs and cats using structured behavioural observation |
Q90210530 | Persistence of pain in humans and other mammals |
Q92862432 | Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis |
Q95276429 | Preliminary clinical experience of low-level laser therapy for the treatment of canine osteoarthritis-associated pain: A retrospective investigation on 17 dogs |
Q33861708 | Psychometric evaluation of the canine brief pain inventory in a Swedish sample of dogs with pain related to osteoarthritis. |
Q28083927 | Quality of life assessment in domestic dogs: An evidence-based rapid review |
Q27016146 | Quality of life measurement in prospective studies of cancer treatments in dogs and cats |
Q44221952 | Randomized, controlled clinical trial evaluating the efficacy of pulsed signal therapy in dogs with osteoarthritis |
Q44867358 | Reliability and discriminatory testing of a client-based metrology instrument, feline musculoskeletal pain index (FMPI) for the evaluation of degenerative joint disease-associated pain in cats. |
Q26741184 | Resiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain Relief |
Q37280064 | Salivary cortisol concentrations and behavior in a population of healthy dogs hospitalized for elective procedures |
Q43753026 | The Canine Orthopedic Index. Step 1: Devising the items |
Q48083439 | The Canine Orthopedic Index. Step 3: Responsiveness testing |
Q38086098 | The challenges of assessing osteoarthritis and postoperative pain in dogs |
Q34901701 | The vanilloid agonist resiniferatoxin for interventional-based pain control |
Q98613574 | Treatment of canine osteoarthritis with allogeneic platelet-rich plasma: review of five cases |
Q34000008 | Use of an activity monitor to detect response to treatment in dogs with osteoarthritis |
Q36900120 | Widespread somatosensory sensitivity in naturally occurring canine model of osteoarthritis. |
Search more.